Grantham, Mayo, Van Otterloo & Co (GMO)
CTSH icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Cognizant CTSH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CTSH Stock Details CTSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39M Buy
635,403
+111,161
+21% +$7.95M 0.1% 92
2025
Q4 		$43.5M Buy
524,242
+25,033
+5% +$1.87M 0.11% 79
2025
Q3 		$33.5M Sell
499,209
-8,466
-2% -$612K 0.09% 116
2025
Q2 		$39.6M Sell
507,675
-116,528
-19% -$8.93M 0.12% 92
2025
Q1 		$47.8M Sell
624,203
-10,144
-2% -$826K 0.15% 71
2024
Q4 		$48.8M Sell
634,347
-40,885
-6% -$3.2M 0.16% 71
2024
Q3 		$52.1M Buy
675,232
+8,746
+1% +$652K 0.16% 80
2024
Q2 		$45.3M Sell
666,486
-903
-0.1% -$61.2K 0.15% 86
2024
Q1 		$48.9M Sell
667,389
-58,981
-8% -$4.51M 0.18% 82
2023
Q4 		$54.9M Buy
726,370
+37,050
+5% +$2.56M 0.24% 70
2023
Q3 		$46.7M Sell
689,320
-17,007
-2% -$1.17M 0.22% 80
2023
Q2 		$46.1M Buy
706,327
+48,809
+7% +$3.02M 0.21% 84
2023
Q1 		$40.1M Buy
657,518
+55,500
+9% +$3.48M 0.2% 95
2022
Q4 		$34.4M Buy
602,018
+183,818
+44% +$10.8M 0.18% 117
2022
Q3 		$24M Buy
418,200
+30,900
+8% +$2.02M 0.14% 159
2022
Q2 		$26.1M Buy
387,300
+17,700
+5% +$1.35M 0.14% 155
2022
Q1 		$33.1M Buy
369,600
+700
+0.2% +$61.5K 0.16% 108
2021
Q4 		$32.7M Sell
368,900
-8,200
-2% -$659K 0.16% 108
2021
Q3 		$28M Buy
377,100
+38,600
+11% +$2.85M 0.14% 126
2021
Q2 		$23.4M Buy
338,500
+81,600
+32% +$6.08M 0.12% 147
2021
Q1 		$20.1M Buy
256,900
+85,800
+50% +$6.63M 0.11% 149
2020
Q4 		$14M Buy
+171,100
New +$13M 0.09% 160
2020
Q2 		– Sell
-3,222,311
Closed -$150M – 770
2020
Q1 		$150M Buy
3,222,311
+3,790
+0.1% +$226K 1.25% 24
2019
Q4 		$200M Sell
3,218,521
-558,759
-15% -$34.5M 1.33% 24
2019
Q3 		$228M Buy
3,777,280
+96,059
+3% +$6.07M 1.58% 18
2019
Q2 		$233M Buy
3,681,221
+486,438
+15% +$31.9M 1.64% 18
2019
Q1 		$231M Sell
3,194,783
-140,650
-4% -$9.84M 1.66% 19
2018
Q4 		$212M Buy
3,335,433
+121,648
+4% +$8.46M 1.69% 20
2018
Q3 		$248M Sell
3,213,785
-176,530
-5% -$13.8M 1.68% 20
2018
Q2 		$268M Sell
3,390,315
-501,513
-13% -$39.4M 1.9% 14
2018
Q1 		$313M Sell
3,891,828
-79,858
-2% -$6.31M 1.92% 10
2017
Q4 		$282M Sell
3,971,686
-48,496
-1% -$3.54M 1.66% 14
2017
Q3 		$292M Sell
4,020,182
-487,014
-11% -$34.2M 1.7% 16
2017
Q2 		$299M Buy
4,507,196
+157,585
+4% +$10M 1.65% 15
2017
Q1 		$259M Buy
4,349,611
+346,747
+9% +$19.9M 1.46% 16
2016
Q4 		$224M Buy
4,002,864
+181,877
+5% +$9.73M 1.21% 17
2016
Q3 		$182M Buy
3,820,987
+721,448
+23% +$41M 0.86% 23
2016
Q2 		$177M Buy
3,099,539
+1,217,120
+65% +$73.5M 0.73% 32
2016
Q1 		$118M Sell
1,882,419
-87,674
-4% -$5.1M 0.44% 54
2015
Q4 		$118M Sell
1,970,093
-247,682
-11% -$16M 0.43% 59
2015
Q3 		$139M Sell
2,217,775
-544,273
-20% -$34.2M 0.48% 45
2015
Q2 		$169M Sell
2,762,048
-892,600
-24% -$56M 0.54% 43
2015
Q1 		$228M Sell
3,654,648
-230,232
-6% -$13.6M 0.68% 36
2014
Q4 		$205M Buy
3,884,880
+206,147
+6% +$10.3M 0.55% 42
2014
Q3 		$165M Buy
3,678,733
+448,383
+14% +$21.1M 0.44% 47
2014
Q2 		$158M Buy
3,230,350
+260,640
+9% +$12.7M 0.43% 48
2014
Q1 		$150M Buy
2,969,710
+1,247,774
+72% +$62.4M 0.39% 50
2013
Q4 		$86.9M Buy
1,721,936
+840,612
+95% +$38.3M 0.21% 69
2013
Q3 		$36.2M Buy
881,324
+334,460
+61% +$12.4M 0.1% 95
2013
Q2 		$17.1M Buy
+546,864
New +$18.2M 0.04% 153

Other funds holding CTSH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CTSH Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Cognizant (CTSH) stake by 21% in Q1 2026, buying an estimated $7.95M and bringing the position to 635,403 shares worth $39M. The position accounts for 0.1% of the portfolio, ranked #92.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CTSH in Q2 2013 and has held it in 50 quarters since. The position peaked at $313M in Q1 2018. 985 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 635,403 shares of Cognizant worth $39M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 111,161 Cognizant shares in Q1 2026, an estimated $7.95M.
  • Cognizant made up 0.1% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #92 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cognizant in Q2 2013 and has held it in 50 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cognizant position peaked at $313M in Q1 2018.
  • 985 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.